Additionally, prophylactic and therapeutic administration of Lm-MPFG resulted in significantly reduced number of Tregs in tumors and reduced production of anti-inflammatory cytokines such as TGF-β and IL-10 by the tumor-infiltrating Tregs. This evidence concerns the gene IL10 and neoplasm.